Absci (ABSI) Financials

$3.03 0.00 (0.00%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$3.04 +0.01 (+0.30%)

As of 05/2/2025 07:58 PM Eastern

Annual Income Statements for Absci

This table shows Absci's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-105	-111	-103
Consolidated Net Income / (Loss)	-105	-111	-103
Net Income / (Loss) Continuing Operations	-105	-111	-103
Total Pre-Tax Income	-105	-110	-103
Total Operating Income	-107	-116	-109
Total Gross Profit	5.75	5.72	4.53
Total Revenue	5.75	5.72	4.53
Operating Revenue	5.75	5.72	4.53
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	112	121	113
Selling, General & Admin Expense	41	38	36
Research & Development Expense	59	48	64
Depreciation Expense	13	14	13
Impairment Charge	0.00	21	0.00
Total Other Income / (Expense), net	1.39	5.05	5.85
Interest Expense	0.97	1.01	0.57
Other Income / (Expense), net	2.36	6.06	6.42
Income Tax Expense	-0.46	0.10	0.07
Basic Earnings per Share	($1.15)	($1.20)	($0.94)
Weighted Average Basic Shares Outstanding	90.85M	92.03M	110.24M
Diluted Earnings per Share	($1.15)	($1.20)	($0.94)
Weighted Average Diluted Shares Outstanding	90.85M	92.03M	110.24M
Weighted Average Basic & Diluted Shares Outstanding	92.32M	112.78M	127.33M

This table shows Absci's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-27	-19	-23	-42	-22	-24	-22	-25	-27	-29
Consolidated Net Income / (Loss)	-27	-19	-23	-42	-22	-24	-22	-25	-27	-29
Net Income / (Loss) Continuing Operations	-27	-19	-23	-42	-22	-24	-22	-25	-27	-29
Total Pre-Tax Income	-28	-20	-23	-42	-22	-23	-22	-25	-27	-29
Total Operating Income	-28	-21	-24	-43	-23	-25	-23	-27	-29	-30
Total Gross Profit	2.37	1.56	1.27	3.37	0.74	0.34	0.90	1.27	1.70	0.67
Total Revenue	2.37	1.56	1.27	3.37	0.74	0.34	0.90	1.27	1.70	0.67
Operating Revenue	2.37	1.56	1.27	3.37	0.74	0.34	0.90	1.27	1.70	0.67
Total Operating Expenses	30	23	26	46	24	25	24	28	31	30
Selling, General & Admin Expense	11	7.75	9.59	9.41	9.51	9.32	8.74	9.35	9.26	8.83
Research & Development Expense	16	11	13	12	11	12	12	15	18	18
Depreciation Expense	3.40	3.59	3.50	3.50	3.51	3.48	3.42	3.38	3.36	3.23
Total Other Income / (Expense), net	0.40	1.12	1.14	1.33	1.34	1.24	1.54	1.97	1.53	0.81
Interest Expense	0.28	0.29	0.32	0.26	0.23	0.20	0.18	0.15	0.13	0.11
Other Income / (Expense), net	0.68	1.41	1.46	1.58	1.57	1.45	1.71	2.12	1.66	0.92
Income Tax Expense	-0.31	-0.50	0.01	0.01	0.03	0.05	0.01	0.00	0.04	0.02
Basic Earnings per Share	($0.30)	($0.20)	($0.26)	($0.45)	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)
Weighted Average Basic Shares Outstanding	91.11M	90.85M	91.48M	91.83M	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M
Diluted Earnings per Share	($0.30)	($0.20)	($0.26)	($0.45)	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)
Weighted Average Diluted Shares Outstanding	91.11M	90.85M	91.48M	91.83M	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M
Weighted Average Basic & Diluted Shares Outstanding	92.39M	92.32M	92.50M	92.71M	92.94M	112.78M	113.08M	113.56M	114.86M	127.33M

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-203	13	-31
Net Cash From Operating Activities	-81	-65	-72
Net Cash From Continuing Operating Activities	-81	-65	-72
Net Income / (Loss) Continuing Operations	-105	-111	-103
Consolidated Net Income / (Loss)	-105	-111	-103
Depreciation Expense	13	14	13
Amortization Expense	-0.69	-2.67	-3.74
Non-Cash Adjustments To Reconcile Net Income	13	33	19
Changes in Operating Assets and Liabilities, net	-1.32	1.85	1.61
Net Cash From Investing Activities	-127	82	-42
Net Cash From Continuing Investing Activities	-127	82	-42
Purchase of Property, Plant & Equipment	-16	-0.86	-0.40
Purchase of Investments	-109	-147	-186
Sale of Property, Plant & Equipment	0.13	0.25	0.94
Sale and/or Maturity of Investments	5.00	230	144
Net Cash From Financing Activities	5.24	-4.48	83
Net Cash From Continuing Financing Activities	5.24	-4.48	83
Repayment of Debt	-4.65	-3.01	-3.39
Issuance of Common Equity	0.66	0.86	87
Other Financing Activities, net	-2.80	-2.33	-0.64
Cash Interest Paid	0.90	0.97	0.56

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-99	-47	-49	50	8.85	2.80	-13	-16	-5.44	3.07
Net Cash From Operating Activities	-19	-19	-20	-19	-10	-15	-18	-17	-21	-17
Net Cash From Continuing Operating Activities	-19	-19	-20	-19	-10	-15	-18	-17	-21	-17
Net Income / (Loss) Continuing Operations	-27	-19	-23	-42	-22	-24	-22	-25	-27	-29
Consolidated Net Income / (Loss)	-27	-19	-23	-42	-22	-24	-22	-25	-27	-29
Depreciation Expense	3.40	3.59	3.50	3.50	3.51	3.48	3.42	3.38	3.36	3.23
Amortization Expense	-	-0.69	-0.83	-0.81	-0.63	-0.40	-0.63	-1.21	-1.12	-0.78
Non-Cash Adjustments To Reconcile Net Income	3.57	1.02	2.65	24	2.56	3.18	3.59	5.28	5.52	5.07
Changes in Operating Assets and Liabilities, net	1.25	-3.02	-2.09	-4.61	6.19	2.36	-2.26	0.46	-1.09	4.50
Net Cash From Investing Activities	-79	-30	-27	70	20	19	-77	1.26	15	19
Net Cash From Continuing Investing Activities	-79	-30	-27	70	20	19	-77	1.26	15	19
Purchase of Property, Plant & Equipment	-4.87	-0.56	-0.28	-0.26	-0.31	-0.02	0.00	-0.33	-0.05	-0.02
Purchase of Investments	-74	-35	-69	-24	-30	-25	-97	-34	-28	-27
Sale of Property, Plant & Equipment	-	0.12	0.05	0.07	0.01	0.13	0.15	-	0.10	0.70
Sale and/or Maturity of Investments	-	5.00	42	94	50	44	21	36	43	45
Net Cash From Financing Activities	-0.92	1.39	-1.10	-1.22	-0.92	-1.24	81	-0.13	0.49	0.99
Net Cash From Continuing Financing Activities	-0.92	1.39	-1.10	-1.22	-0.92	-1.24	81	-0.13	0.49	0.99
Repayment of Debt	-0.39	-0.57	-0.66	-0.75	-0.76	-0.84	-0.87	-0.80	-0.82	-0.90
Issuance of Common Equity	0.16	0.07	0.23	0.12	0.38	0.14	82	0.76	1.39	1.95
Other Financing Activities, net	-0.70	-0.73	-0.67	-0.59	-0.54	-0.53	-0.40	-0.09	-0.08	-0.07

This table presents Absci's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	321	217	214
Total Current Assets	187	121	134
Cash & Equivalents	60	72	41
Restricted Cash	15	16	16
Short-Term Investments	104	25	71
Accounts Receivable	-	2.19	0.00
Prepaid Expenses	5.86	4.54	5.46
Plant, Property, & Equipment, net	0.00	0.00	0.00
Total Noncurrent Assets	134	97	80
Intangible Assets	52	48	45
Other Noncurrent Operating Assets	61	48	35
Total Liabilities & Shareholders' Equity	321	217	214
Total Liabilities	47	41	34
Total Current Liabilities	30	30	29
Short-Term Debt	2.95	16	15
Accounts Payable	2.41	1.50	3.53
Accrued Expenses	20	6.55	6.84
Current Deferred Revenue	0.45	3.17	1.12
Other Current Liabilities	3.99	2.32	1.69
Total Noncurrent Liabilities	16	12	5.82
Long-Term Debt	7.98	4.66	1.26
Capital Lease Obligations	0.75	5.64	4.43
Noncurrent Deferred Revenue	0.00	0.97	0.00
Other Noncurrent Operating Liabilities	7.35	0.30	0.13
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	274	176	179
Total Preferred & Common Equity	274	176	179
Preferred Stock	0.00	0.00	0.00
Total Common Equity	274	176	179
Common Stock	570	583	689
Retained Earnings	-296	-406	-510
Accumulated Other Comprehensive Income / (Loss)	-0.12	-0.04	-0.00

This table presents Absci's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	339	296	254	236	275	256	235
Total Current Assets	201	165	148	135	182	165	150
Cash & Equivalents	107	11	61	70	59	43	38
Restricted Cash	15	15	15	16	16	17	16
Short-Term Investments	74	133	64	44	103	102	89
Note & Lease Receivable	0.21	1.33	3.16	0.80	0.04	0.04	1.50
Prepaid Expenses	4.84	4.71	5.23	4.40	3.86	3.39	5.78
Plant, Property, & Equipment, net	0.00	50	0.00	0.00	39	0.00	0.00
Total Noncurrent Assets	138	80	106	102	54	90	85
Intangible Assets	52	51	50	49	47	47	46
Other Noncurrent Operating Assets	64	8.21	56	53	6.93	44	39
Total Liabilities & Shareholders' Equity	339	296	254	236	275	256	235
Total Liabilities	46	42	39	40	35	34	34
Total Current Liabilities	30	27	25	28	25	25	27
Short-Term Debt	2.35	3.08	3.15	3.21	3.30	3.12	3.27
Accounts Payable	1.86	1.93	1.85	1.91	1.65	1.69	1.67
Accrued Expenses	21	18	17	20	15	17	18
Current Deferred Revenue	0.68	0.36	0.50	0.35	3.06	1.97	1.78
Other Current Liabilities	4.16	3.74	3.28	2.83	1.87	1.82	1.71
Total Noncurrent Liabilities	16	15	13	12	9.50	8.57	7.21
Long-Term Debt	6.52	7.19	6.38	5.55	3.75	3.12	2.16
Capital Lease Obligations	9.11	7.23	0.25	6.16	5.33	5.26	4.85
Noncurrent Deferred Revenue	-	-	-	-	0.18	0.00	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	0.76	0.22	0.22	0.25	0.18	0.18	0.18
Other Noncurrent Operating Liabilities	0.03	0.00	6.42	0.00	0.08	0.02	0.03
Total Equity & Noncontrolling Interests	293	254	215	196	240	221	201
Total Preferred & Common Equity	293	254	215	196	240	221	201
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	293	254	215	196	240	221	201
Common Stock	569	573	577	579	669	675	682
Retained Earnings	-276	-319	-361	-383	-428	-453	-481
Accumulated Other Comprehensive Income / (Loss)	0.03	-0.10	-0.15	-0.06	-0.13	-0.11	0.25

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	20.18%	-0.50%	-20.71%
EBITDA Growth	7.75%	-6.61%	5.40%
EBIT Growth	1.91%	-4.85%	6.38%
NOPAT Growth	-41.88%	-8.21%	5.74%
Net Income Growth	-3.91%	-5.40%	6.75%
EPS Growth	44.71%	-4.35%	21.67%
Operating Cash Flow Growth	-34.23%	20.54%	-12.02%
Free Cash Flow Firm Growth	51.30%	15.99%	5.31%
Invested Capital Growth	0.09%	-16.88%	-18.85%
Revenue Q/Q Growth	1.86%	-17.57%	7.77%
EBITDA Q/Q Growth	6.62%	-3.61%	-7.15%
EBIT Q/Q Growth	5.76%	-3.41%	-5.74%
NOPAT Q/Q Growth	4.61%	-3.26%	-4.85%
Net Income Q/Q Growth	5.15%	-3.83%	-5.57%
EPS Q/Q Growth	-394.87%	-4.35%	-1.08%
Operating Cash Flow Q/Q Growth	-1.86%	5.34%	-2.90%
Free Cash Flow Firm Q/Q Growth	0.00%	-38.03%	0.17%
Invested Capital Q/Q Growth	-6.94%	8.33%	4.63%
Profitability Metrics	-	-	-
Gross Margin	100.00%	100.00%	100.00%
EBITDA Margin	-1,601.60%	-1,716.12%	-2,047.31%
Operating Margin	-1,857.49%	-2,020.20%	-2,401.59%
EBIT Margin	-1,816.48%	-1,914.24%	-2,260.06%
Profit (Net Income) Margin	-1,825.37%	-1,933.65%	-2,274.06%
Tax Burden Percent	99.56%	100.09%	100.07%
Interest Burden Percent	100.93%	100.92%	100.55%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-70.10%	-82.82%	-94.94%
ROIC Less NNEP Spread (ROIC-NNEP)	-55.98%	-59.55%	-67.33%
Return on Net Nonoperating Assets (RNNOA)	37.35%	33.74%	36.90%
Return on Equity (ROE)	-32.76%	-49.08%	-58.04%
Cash Return on Invested Capital (CROIC)	-70.19%	-64.38%	-74.13%
Operating Return on Assets (OROA)	-27.94%	-40.67%	-47.56%
Return on Assets (ROA)	-28.08%	-41.08%	-47.86%
Return on Common Equity (ROCE)	-32.76%	-49.08%	-58.04%
Return on Equity Simple (ROE_SIMPLE)	-38.23%	-62.76%	-57.56%
Net Operating Profit after Tax (NOPAT)	-75	-81	-76
NOPAT Margin	-1,300.24%	-1,414.14%	-1,681.11%
Net Nonoperating Expense Percent (NNEP)	-14.12%	-23.27%	-27.61%
Return On Investment Capital (ROIC_SIMPLE)	-	-39.93%	-38.05%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	705.62%	661.63%	797.84%
R&D to Revenue	1,025.02%	840.63%	1,408.45%
Operating Expenses to Revenue	1,957.49%	2,120.20%	2,501.59%
Earnings before Interest and Taxes (EBIT)	-104	-109	-102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-92	-98	-93
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.71	2.22	1.68
Price to Tangible Book Value (P/TBV)	0.96	3.05	2.24
Price to Revenue (P/Rev)	33.76	68.27	66.37
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.25	3.42	2.69
Enterprise Value to Revenue (EV/Rev)	4.57	52.96	42.73
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.04	0.15	0.12
Long-Term Debt to Equity	0.03	0.06	0.03
Financial Leverage	-0.67	-0.57	-0.55
Leverage Ratio	1.17	1.19	1.21
Compound Leverage Factor	1.18	1.21	1.22
Debt to Total Capital	4.08%	12.99%	10.57%
Short-Term Debt to Total Capital	1.03%	7.91%	7.73%
Long-Term Debt to Total Capital	3.05%	5.09%	2.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	95.92%	87.01%	89.43%
Debt to EBITDA	-0.13	-0.27	-0.23
Net Debt to EBITDA	1.82	0.89	1.15
Long-Term Debt to EBITDA	-0.09	-0.11	-0.06
Debt to NOPAT	-0.16	-0.33	-0.28
Net Debt to NOPAT	2.25	1.08	1.41
Long-Term Debt to NOPAT	-0.12	-0.13	-0.07
Altman Z-Score	0.74	1.94	0.93
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	6.17	4.08	4.67
Quick Ratio	5.48	3.38	3.92
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-75	-63	-60
Operating Cash Flow to CapEx	-507.04%	-10,666.01%	0.00%
Free Cash Flow to Firm to Interest Expense	-76.97	-62.23	-105.34
Operating Cash Flow to Interest Expense	-83.68	-64.00	-128.15
Operating Cash Flow Less CapEx to Interest Expense	-100.19	-64.60	-127.20
Efficiency Ratios	-	-	-
Asset Turnover	0.02	0.02	0.02
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	107	89	72
Invested Capital Turnover	0.05	0.06	0.06
Increase / (Decrease) in Invested Capital	0.09	-18	-17
Enterprise Value (EV)	26	303	194
Market Capitalization	194	390	301
Book Value per Share	$2.97	$1.90	$1.56
Tangible Book Value per Share	$2.18	$1.38	$1.17
Total Capital	286	202	200
Total Debt	12	26	21
Total Long-Term Debt	8.73	10	5.69
Net Debt	-168	-88	-107
Capital Expenditures (CapEx)	16	0.61	-0.54
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-20	-6.82	-7.71
Debt-free Net Working Capital (DFNWC)	160	107	121
Net Working Capital (NWC)	157	91	105
Net Nonoperating Expense (NNE)	30	30	27
Net Nonoperating Obligations (NNO)	-168	-88	-107
Total Depreciation and Amortization (D&A)	12	11	9.65
Debt-free, Cash-free Net Working Capital to Revenue	-346.53%	-119.34%	-170.14%
Debt-free Net Working Capital to Revenue	2,776.04%	1,871.77%	2,661.18%
Net Working Capital to Revenue	2,724.78%	1,591.82%	2,319.70%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.15)	($1.20)	($0.94)
Adjusted Weighted Average Basic Shares Outstanding	90.85M	92.03M	110.24M
Adjusted Diluted Earnings per Share	($1.15)	($1.20)	($0.94)
Adjusted Weighted Average Diluted Shares Outstanding	90.85M	92.03M	110.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	92.32M	112.78M	127.33M
Normalized Net Operating Profit after Tax (NOPAT)	-75	-66	-76
Normalized NOPAT Margin	-1,300.24%	-1,152.96%	-1,681.11%
Pre Tax Income Margin	-1,833.39%	-1,931.90%	-2,272.52%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-107.40	-108.37	-181.36
NOPAT to Interest Expense	-76.88	-80.06	-134.91
EBIT Less CapEx to Interest Expense	-123.90	-108.97	-180.42
NOPAT Less CapEx to Interest Expense	-93.38	-80.66	-133.96
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	53.93%	7.23%	54.95%	236.03%	-68.59%	-78.29%	-29.24%	-62.28%	128.63%	96.75%
EBITDA Growth	-6.88%	27.98%	21.02%	-51.27%	21.10%	-20.37%	6.65%	42.08%	-32.62%	-30.67%
EBIT Growth	-11.08%	24.49%	19.71%	-44.07%	20.38%	-18.33%	5.39%	40.59%	-25.31%	-23.87%
NOPAT Growth	-32.28%	19.66%	14.99%	-48.81%	16.68%	-17.29%	4.03%	37.84%	-24.00%	-20.35%
Net Income Growth	-15.34%	22.63%	20.81%	-45.30%	19.31%	-20.92%	5.91%	40.61%	-24.57%	-23.10%
EPS Growth	9.09%	-114.93%	21.21%	-40.63%	20.00%	-25.00%	15.38%	51.11%	0.00%	-4.00%
Operating Cash Flow Growth	12.43%	-8.72%	4.87%	14.81%	45.59%	19.64%	11.21%	12.43%	-100.10%	-13.68%
Free Cash Flow Firm Growth	77.05%	0.00%	80.93%	77.17%	159.18%	104.63%	188.33%	52.72%	-143.44%	-701.54%
Invested Capital Growth	7.74%	0.09%	6.45%	-19.50%	-28.60%	-16.88%	-33.51%	-16.69%	-15.98%	-18.85%
Revenue Q/Q Growth	136.43%	-34.28%	-18.50%	165.33%	-77.90%	-54.57%	165.68%	41.43%	33.94%	-60.91%
EBITDA Q/Q Growth	6.68%	29.73%	-21.26%	-90.23%	51.33%	-7.21%	5.95%	-18.03%	-11.44%	-5.63%
EBIT Q/Q Growth	5.04%	27.88%	-16.98%	-79.81%	47.52%	-7.19%	6.47%	-12.91%	-10.70%	-5.96%
NOPAT Q/Q Growth	3.18%	24.58%	-16.08%	-75.57%	45.79%	-6.16%	5.02%	-13.72%	-8.14%	-3.04%
Net Income Q/Q Growth	4.95%	28.57%	-19.95%	-78.43%	47.22%	-7.05%	6.67%	-12.63%	-10.70%	-5.79%
EPS Q/Q Growth	6.25%	33.33%	-30.00%	-73.08%	46.67%	-4.17%	12.00%	0.00%	-9.09%	-8.33%
Operating Cash Flow Q/Q Growth	15.66%	2.49%	-8.35%	4.40%	46.13%	-44.02%	-19.71%	5.71%	-23.09%	18.17%
Free Cash Flow Firm Q/Q Growth	32.26%	46.58%	-61.12%	60.84%	275.59%	-95.82%	11.25%	-120.96%	-61.33%	42.14%
Invested Capital Q/Q Growth	7.87%	-6.94%	5.19%	-23.77%	-4.32%	8.33%	6.07%	-4.48%	-3.51%	4.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-1,008.36%	-1,078.10%	-1,604.02%	-1,150.01%	-2,533.20%	-5,977.81%	-2,116.04%	-1,765.98%	-1,469.37%	-3,970.08%
Operating Margin	-1,180.54%	-1,354.72%	-1,929.47%	-1,276.74%	-3,132.12%	-7,319.23%	-2,616.70%	-2,104.02%	-1,698.71%	-4,477.29%
EBIT Margin	-1,152.05%	-1,264.23%	-1,814.58%	-1,229.73%	-2,920.83%	-6,891.42%	-2,426.17%	-1,937.01%	-1,600.88%	-4,338.80%
Profit (Net Income) Margin	-1,150.65%	-1,250.55%	-1,840.43%	-1,237.66%	-2,956.18%	-6,965.98%	-2,447.10%	-1,948.82%	-1,610.70%	-4,358.35%
Tax Burden Percent	98.87%	97.50%	100.03%	100.03%	100.15%	100.20%	100.05%	100.00%	100.14%	100.07%
Interest Burden Percent	101.02%	101.46%	101.39%	100.62%	101.05%	100.88%	100.81%	100.61%	100.48%	100.38%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-42.20%	-51.13%	-76.94%	-79.81%	-154.87%	-300.05%	-104.88%	-61.07%	-66.45%	-177.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-38.86%	-48.93%	-73.65%	-73.00%	-150.99%	-295.17%	-101.29%	-56.75%	-60.65%	-168.64%
Return on Net Nonoperating Assets (RNNOA)	26.25%	32.64%	46.69%	46.67%	90.39%	167.25%	63.00%	36.39%	37.69%	92.43%
Return on Equity (ROE)	-15.95%	-18.49%	-30.25%	-33.15%	-64.48%	-132.80%	-41.88%	-24.68%	-28.76%	-84.57%
Cash Return on Invested Capital (CROIC)	0.00%	-70.19%	-72.17%	-63.47%	-46.37%	-64.38%	-45.60%	-69.55%	-79.20%	-74.13%
Operating Return on Assets (OROA)	-16.49%	-19.45%	-32.53%	-33.94%	-70.39%	-146.40%	-45.46%	-24.70%	-28.56%	-91.31%
Return on Assets (ROA)	-16.47%	-19.24%	-33.00%	-34.16%	-71.24%	-147.99%	-45.85%	-24.85%	-28.74%	-91.72%
Return on Common Equity (ROCE)	-15.95%	-18.49%	-30.25%	-33.15%	-64.48%	-132.80%	-41.88%	-24.68%	-28.76%	-84.57%
Return on Equity Simple (ROE_SIMPLE)	-37.75%	0.00%	-38.89%	-51.88%	-54.22%	0.00%	-45.47%	-41.66%	-48.51%	0.00%
Net Operating Profit after Tax (NOPAT)	-20	-15	-17	-30	-16	-17	-16	-19	-20	-21
NOPAT Margin	-826.38%	-948.30%	-1,350.63%	-893.72%	-2,192.49%	-5,123.46%	-1,831.69%	-1,472.81%	-1,189.09%	-3,134.11%
Net Nonoperating Expense Percent (NNEP)	-3.34%	-2.20%	-3.30%	-6.82%	-3.88%	-4.88%	-3.60%	-4.32%	-5.80%	-8.36%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-8.55%	-	-	-	-10.41%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	481.51%	497.69%	755.95%	279.48%	1,277.55%	2,758.58%	973.72%	735.91%	544.15%	1,327.52%
R&D to Revenue	655.34%	726.72%	997.40%	359.73%	1,482.39%	3,629.88%	1,362.58%	1,201.65%	1,057.32%	2,763.46%
Operating Expenses to Revenue	1,280.54%	1,454.72%	2,029.47%	1,376.74%	3,232.12%	7,419.23%	2,716.70%	2,204.02%	1,798.71%	4,577.29%
Earnings before Interest and Taxes (EBIT)	-27	-20	-23	-41	-22	-23	-22	-25	-27	-29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-24	-17	-20	-39	-19	-20	-19	-22	-25	-26
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.99	0.71	0.64	0.65	0.62	2.22	2.67	1.57	2.15	1.68
Price to Tangible Book Value (P/TBV)	1.33	0.96	0.89	0.85	0.83	3.05	3.32	1.99	2.79	2.24
Price to Revenue (P/Rev)	51.51	33.76	26.07	16.42	17.64	68.27	119.81	107.17	103.11	66.37
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.98	0.25	0.18	0.13	0.10	3.42	6.37	2.78	4.38	2.69
Enterprise Value to Revenue (EV/Rev)	19.90	4.57	3.19	1.25	1.12	52.96	88.85	60.94	71.59	42.73
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.04	0.07	0.05	0.08	0.15	0.05	0.05	0.05	0.12
Long-Term Debt to Equity	0.05	0.03	0.06	0.03	0.06	0.06	0.04	0.04	0.03	0.03
Financial Leverage	-0.68	-0.67	-0.63	-0.64	-0.60	-0.57	-0.62	-0.64	-0.62	-0.55
Leverage Ratio	1.16	1.17	1.16	1.17	1.18	1.19	1.16	1.17	1.19	1.21
Compound Leverage Factor	1.17	1.18	1.18	1.17	1.19	1.21	1.16	1.17	1.19	1.22
Debt to Total Capital	5.78%	4.08%	6.45%	4.34%	7.06%	12.99%	4.90%	4.94%	4.86%	10.57%
Short-Term Debt to Total Capital	0.76%	1.03%	1.13%	1.40%	1.52%	7.91%	1.31%	1.34%	1.55%	7.73%
Long-Term Debt to Total Capital	5.03%	3.05%	5.31%	2.94%	5.54%	5.09%	3.59%	3.60%	3.31%	2.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	94.22%	95.92%	93.55%	95.66%	92.94%	87.01%	95.10%	95.06%	95.14%	89.43%
Debt to EBITDA	-0.18	-0.13	-0.20	-0.10	-0.16	-0.27	-0.13	-0.14	-0.12	-0.23
Net Debt to EBITDA	1.81	1.82	1.64	1.30	1.21	0.89	1.71	1.87	1.53	1.15
Long-Term Debt to EBITDA	-0.16	-0.09	-0.17	-0.07	-0.12	-0.11	-0.09	-0.10	-0.08	-0.06
Debt to NOPAT	-0.23	-0.16	-0.24	-0.12	-0.19	-0.33	-0.15	-0.17	-0.14	-0.28
Net Debt to NOPAT	2.28	2.25	1.98	1.59	1.46	1.08	2.06	2.18	1.82	1.41
Long-Term Debt to NOPAT	-0.20	-0.12	-0.20	-0.08	-0.15	-0.13	-0.11	-0.12	-0.10	-0.07
Altman Z-Score	2.97	1.61	1.13	0.26	-0.16	3.25	9.31	4.01	5.08	2.06
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.71	6.17	6.08	5.81	4.82	4.08	7.19	6.49	5.63	4.67
Quick Ratio	6.05	5.48	5.35	5.01	4.09	3.38	6.39	5.71	4.82	3.92
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-28	-15	-24	-9.37	16	0.69	21	-4.43	-7.15	-4.14
Operating Cash Flow to CapEx	-391.03%	-4,200.91%	-8,824.12%	-10,070.16%	-3,500.34%	0.00%	0.00%	-5,057.96%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-99.68	-51.76	-74.57	-36.62	71.87	3.37	120.13	-29.54	-55.00	-37.95
Operating Cash Flow to Interest Expense	-68.25	-64.70	-62.68	-75.13	-45.24	-73.15	-101.49	-112.29	-159.48	-155.63
Operating Cash Flow Less CapEx to Interest Expense	-85.71	-66.24	-63.39	-75.88	-46.54	-72.61	-100.65	-114.51	-159.12	-149.47
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.01	0.02	0.02	0.03	0.02	0.02	0.02	0.01	0.02	0.02
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.12	0.00	0.00	0.00	0.12	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	115	107	112	86	82	89	75	71	69	72
Invested Capital Turnover	0.05	0.05	0.06	0.09	0.07	0.06	0.06	0.04	0.06	0.06
Increase / (Decrease) in Invested Capital	8.23	0.09	6.80	-21	-33	-18	-38	-14	-13	-17
Enterprise Value (EV)	112	26	20	11	7.78	303	475	198	301	194
Market Capitalization	291	194	162	141	122	390	641	348	434	301
Book Value per Share	$3.16	$2.97	$2.75	$2.35	$2.12	$1.90	$2.13	$1.96	$1.77	$1.56
Tangible Book Value per Share	$2.36	$2.18	$1.97	$1.80	$1.59	$1.38	$1.71	$1.55	$1.37	$1.17
Total Capital	311	286	271	225	211	202	252	233	212	200
Total Debt	18	12	17	9.77	15	26	12	12	10	21
Total Long-Term Debt	16	8.73	14	6.62	12	10	9.07	8.38	7.00	5.69
Net Debt	-178	-168	-142	-130	-115	-88	-166	-150	-133	-107
Capital Expenditures (CapEx)	4.87	0.44	0.23	0.19	0.30	-0.11	-0.15	0.33	-0.05	-0.67
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-23	-20	-18	-14	-20	-6.82	-18	-19	-16	-7.71
Debt-free Net Working Capital (DFNWC)	174	160	141	126	110	107	160	143	127	121
Net Working Capital (NWC)	171	157	138	123	107	91	157	140	123	105
Net Nonoperating Expense (NNE)	7.68	4.71	6.22	12	5.68	6.23	5.53	6.05	7.17	8.14
Net Nonoperating Obligations (NNO)	-178	-168	-142	-130	-115	-88	-166	-150	-133	-107
Total Depreciation and Amortization (D&A)	3.40	2.90	2.67	2.68	2.88	3.09	2.79	2.17	2.24	2.45
Debt-free, Cash-free Net Working Capital to Revenue	-401.01%	-346.53%	-291.93%	-162.99%	-281.98%	-119.34%	-338.17%	-581.88%	-383.58%	-170.14%
Debt-free Net Working Capital to Revenue	3,078.82%	2,776.04%	2,278.43%	1,468.09%	1,585.02%	1,871.77%	2,988.80%	4,395.17%	3,012.36%	2,661.18%
Net Working Capital to Revenue	3,037.10%	2,724.78%	2,228.76%	1,431.36%	1,538.71%	1,591.82%	2,927.06%	4,299.05%	2,934.54%	2,319.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.30)	($0.20)	($0.26)	($0.45)	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)
Adjusted Weighted Average Basic Shares Outstanding	91.11M	90.85M	91.48M	91.83M	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M
Adjusted Diluted Earnings per Share	($0.30)	($0.20)	($0.26)	($0.45)	($0.24)	($0.25)	($0.22)	($0.22)	($0.24)	($0.26)
Adjusted Weighted Average Diluted Shares Outstanding	91.11M	90.85M	91.48M	91.83M	92.22M	92.03M	99.39M	112.93M	113.61M	110.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	92.39M	92.32M	92.50M	92.71M	92.94M	112.78M	113.08M	113.56M	114.86M	127.33M
Normalized Net Operating Profit after Tax (NOPAT)	-20	-15	-17	-15	-16	-17	-16	-19	-20	-21
Normalized NOPAT Margin	-826.38%	-948.30%	-1,350.63%	-450.17%	-2,192.49%	-5,123.46%	-1,831.69%	-1,472.81%	-1,189.09%	-3,134.11%
Pre Tax Income Margin	-1,163.82%	-1,282.66%	-1,839.87%	-1,237.33%	-2,951.61%	-6,951.78%	-2,445.77%	-1,948.82%	-1,608.52%	-4,355.19%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-97.82	-68.59	-71.74	-161.74	-94.90	-114.18	-123.79	-164.00	-209.47	-264.71
NOPAT to Interest Expense	-70.17	-51.45	-53.39	-117.55	-71.23	-84.89	-93.46	-124.70	-155.59	-191.21
EBIT Less CapEx to Interest Expense	-115.28	-70.13	-72.45	-162.48	-96.19	-113.65	-122.94	-166.22	-209.11	-258.54
NOPAT Less CapEx to Interest Expense	-87.62	-52.99	-54.10	-118.29	-72.52	-84.35	-92.61	-126.92	-155.23	-185.04
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Absci's Financials

When does Absci's financial year end?

According to the most recent income statement we have on file, Absci's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Absci's net income changed over the last 2 years?

Below is a breakdown of Absci's net income over the past 5 years:

2022: -$104.90 million
2023: -$110.57 million
2024: -$103.11 million

Check out Absci's forecast to explore projected trends and price targets.

What is Absci's operating income?

Absci's total operating income in 2024 was -$108.89 million, based on the following breakdown:

Total Gross Profit: $4.53 million
Total Operating Expenses: $113.42 million

How has Absci revenue changed over the last 2 years?

Over the last 2 years, Absci's total revenue changed from $5.75 million in 2022 to $4.53 million in 2024, a change of -21.1%.

How much debt does Absci have?

Absci's total liabilities were at $34.48 million at the end of 2024, a 16.2% decrease from 2023, and a 26.0% decrease since 2022.

How much cash does Absci have?

In the past 2 years, Absci's cash and equivalents has ranged from $41.21 million in 2024 to $72.36 million in 2023, and is currently $41.21 million as of their latest financial filing in 2024.

How has Absci's book value per share changed over the last 2 years?

Over the last 2 years, Absci's book value per share changed from 2.97 in 2022 to 1.56 in 2024, a change of -47.5%.

Related Companies

This page (NASDAQ:ABSI) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Absci (ABSI) Financials

Frequently Asked Questions About Absci's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Absci (ABSI) Financials

Annual Income Statements for Absci

Quarterly Income Statements for Absci

Annual Cash Flow Statements for Absci

Quarterly Cash Flow Statements for Absci

Annual Balance Sheets for Absci

Quarterly Balance Sheets for Absci

Annual Metrics and Ratios for Absci

Quarterly Metrics and Ratios for Absci

Frequently Asked Questions About Absci's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools